Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Callen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Research|December 17, 2005
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexRaman Kumar, Paul M Neilsen, Joanne Crawford, et al.
Oncology Reports|March 6, 2010
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcomeDavid F Callen, Carmela Ricciardelli, Miriam Butler, et al.
Genomics|September 6, 2002
Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genesJason A Powell, Alison E Gardner, Anthony J Bais, et al.
Developmental Cell|January 6, 2015
Ankrd11 is a chromatin regulator involved in autism that is essential for neural developmentDenis Gallagher, Anastassia Voronova, Mark A Zander, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
Human Genetics|November 22, 2014
Characterization of ANKRD11 mutations in humans and mice related to KBG syndromeKatherina Walz, Devon Cohen, Paul M Neilsen, et al.
Breast Cancer Research and Treatment|June 22, 2018
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotypeYoon-Sim Yap, Prabhakaran Munusamy, Cindy Lim, et al.
Cancer Research|August 17, 2002
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Marina Kochetkova, Olivia L D McKenzie, Anthony J Bais, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Nature Medicine|May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphomaBjörn Lamprecht, Korden Walter, Stephan Kreher, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Research|December 17, 2005
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexRaman Kumar, Paul M Neilsen, Joanne Crawford, et al.
Oncology Reports|March 6, 2010
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcomeDavid F Callen, Carmela Ricciardelli, Miriam Butler, et al.
Genomics|September 6, 2002
Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genesJason A Powell, Alison E Gardner, Anthony J Bais, et al.
Developmental Cell|January 6, 2015
Ankrd11 is a chromatin regulator involved in autism that is essential for neural developmentDenis Gallagher, Anastassia Voronova, Mark A Zander, et al.
Molecular Cancer Therapeutics|July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress ResponseKathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
Human Genetics|November 22, 2014
Characterization of ANKRD11 mutations in humans and mice related to KBG syndromeKatherina Walz, Devon Cohen, Paul M Neilsen, et al.
Breast Cancer Research and Treatment|June 22, 2018
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotypeYoon-Sim Yap, Prabhakaran Munusamy, Cindy Lim, et al.
Cancer Research|August 17, 2002
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Marina Kochetkova, Olivia L D McKenzie, Anthony J Bais, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Nature Medicine|May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphomaBjörn Lamprecht, Korden Walter, Stephan Kreher, et al.
Pageof 6